Core Laboratories Inc (CLB)

$21.28

+0.16

(+0.76%)▲

Market is closed - opens 8 PM, 25 Nov 2024

Performance

  • $21.09
    $21.76
    $21.28
    downward going graph

    0.89%

    Downside

    Day's Volatility :3.06%

    Upside

    2.18%

    downward going graph
  • $13.82
    $25.13
    $21.28
    downward going graph

    35.06%

    Downside

    52 Weeks Volatility :45.01%

    Upside

    15.32%

    downward going graph

Returns

PeriodCore Laboratories IncSector (Energy)Index (Russel 2000)
3 Months
15.84%
7.6%
0.0%
6 Months
17.37%
6.6%
0.0%
1 Year
14.96%
15.0%
0.0%
3 Years
-17.55%
69.6%
-24.0%

Highlights

Market Capitalization
991.6M
Book Value
$5.34
Dividend Share
0.04
Dividend Yield
0.2%
Earnings Per Share (EPS)
0.54
PE Ratio
39.11
PEG Ratio
1.82
Wall Street Target Price
20.0
Profit Margin
5.01%
Operating Margin TTM
12.35%
Return On Assets TTM
5.89%
Return On Equity TTM
11.16%
Revenue TTM
522.8M
Revenue Per Share TTM
11.16
Quarterly Revenue Growth YOY
7.199999999999999%
Gross Profit TTM
96.1M
EBITDA
71.4M
Diluted Eps TTM
0.54
Quarterly Earnings Growth YOY
0.32
EPS Estimate Current Year
0.82
EPS Estimate Next Year
1.02
EPS Estimate Current Quarter
0.23
EPS Estimate Next Quarter
0.25

Analyst Recommendation

Hold
    0
    0%Buy
    53%Hold
    46%Sell
Based on 15 Wall street analysts offering stock ratings for Core Laboratories Inc(by analysts ranked 0 to 5 stars)
Based on 15 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
00
00
00
Hold
8
8
8
Sell
7
7
7

Analyst Forecast

What analysts predicted

Downside of 6.02%

Current $21.28
Target $20.00

Company Financials

FY18Y/Y Change
Revenue
700.8M
↑ 6.22%
Net Income
79.5M
↓ 4.33%
Net Profit Margin
11.35%
↓ 1.25%
FY19Y/Y Change
Revenue
668.2M
↓ 4.66%
Net Income
102.0M
↑ 28.24%
Net Profit Margin
15.26%
↑ 3.91%
FY20Y/Y Change
Revenue
487.3M
↓ 27.08%
Net Income
-97.1M
↓ 195.19%
Net Profit Margin
-19.92%
↓ 35.18%
FY21Y/Y Change
Revenue
470.3M
↓ 3.49%
Net Income
19.7M
↓ 120.32%
Net Profit Margin
4.19%
↑ 24.11%
FY22Y/Y Change
Revenue
489.7M
↑ 4.14%
Net Income
19.5M
↓ 1.39%
Net Profit Margin
3.97%
↓ 0.22%
FY23Y/Y Change
Revenue
509.8M
↑ 4.1%
Net Income
36.7M
↑ 88.53%
Net Profit Margin
7.19%
↑ 3.22%
Q2 FY23Q/Q Change
Revenue
127.9M
↓ 0.37%
Net Income
22.8M
↑ 862.75%
Net Profit Margin
17.87%
↑ 16.02%
Q3 FY23Q/Q Change
Revenue
125.3M
↓ 1.98%
Net Income
9.3M
↓ 59.48%
Net Profit Margin
7.39%
↓ 10.48%
Q4 FY23Q/Q Change
Revenue
128.2M
↑ 2.29%
Net Income
6.5M
↓ 30.18%
Net Profit Margin
5.04%
↓ 2.35%
Q1 FY24Q/Q Change
Revenue
129.6M
↑ 1.11%
Net Income
3.2M
↓ 50.18%
Net Profit Margin
2.48%
↓ 2.56%
Q2 FY24Q/Q Change
Revenue
130.6M
↑ 0.73%
Net Income
9.0M
↑ 180.5%
Net Profit Margin
6.92%
↑ 4.44%
Q3 FY24Q/Q Change
Revenue
134.4M
↑ 2.93%
Net Income
11.7M
↑ 30.04%
Net Profit Margin
8.74%
↑ 1.82%
FY18Y/Y Change
Total Assets
648.8M
↑ 10.95%
Total Liabilities
487.9M
↑ 11.89%
FY19Y/Y Change
Total Assets
774.7M
↑ 19.4%
Total Liabilities
592.5M
↑ 21.44%
FY20Y/Y Change
Total Assets
568.6M
↓ 26.6%
Total Liabilities
493.0M
↓ 16.8%
FY21Y/Y Change
Total Assets
580.9M
↑ 2.16%
Total Liabilities
419.9M
↓ 14.84%
FY22Y/Y Change
Total Assets
578.4M
↓ 0.43%
Total Liabilities
389.4M
↓ 7.25%
FY23Y/Y Change
Total Assets
586.4M
↑ 1.39%
Total Liabilities
356.6M
↓ 8.43%
Q2 FY23Q/Q Change
Total Assets
601.8M
↑ 1.39%
Total Liabilities
382.2M
↓ 2.85%
Q3 FY23Q/Q Change
Total Assets
592.4M
↓ 1.57%
Total Liabilities
363.0M
↓ 5.04%
Q4 FY23Q/Q Change
Total Assets
586.4M
↓ 1.02%
Total Liabilities
356.6M
↓ 1.76%
Q1 FY24Q/Q Change
Total Assets
588.0M
↑ 0.27%
Total Liabilities
350.5M
↓ 1.7%
Q2 FY24Q/Q Change
Total Assets
597.8M
↑ 1.68%
Total Liabilities
352.1M
↑ 0.45%
Q3 FY24Q/Q Change
Total Assets
600.5M
↑ 0.45%
Total Liabilities
344.0M
↓ 2.29%
FY18Y/Y Change
Operating Cash Flow
111.8M
↓ 10.01%
Investing Cash Flow
-70.6M
↑ 243.63%
Financing Cash Flow
-42.5M
↓ 59.19%
FY19Y/Y Change
Operating Cash Flow
89.5M
↓ 19.94%
Investing Cash Flow
-5.7M
↓ 91.96%
Financing Cash Flow
-85.9M
↑ 102.19%
FY20Y/Y Change
Operating Cash Flow
57.9M
↓ 35.36%
Investing Cash Flow
7.9M
↓ 238.29%
Financing Cash Flow
-63.0M
↓ 26.63%
FY21Y/Y Change
Operating Cash Flow
36.6M
↓ 36.79%
Investing Cash Flow
-10.2M
↓ 230.21%
Financing Cash Flow
-22.5M
↓ 64.35%
FY22Y/Y Change
Operating Cash Flow
25.0M
↓ 31.78%
Investing Cash Flow
-3.9M
↓ 62.28%
Financing Cash Flow
-23.4M
↑ 4.08%
Q2 FY23Q/Q Change
Operating Cash Flow
8.8M
↓ 377.09%
Investing Cash Flow
-3.4M
↑ 66.24%
Financing Cash Flow
1.2K
↓ 99.98%
Q3 FY23Q/Q Change
Operating Cash Flow
-215.9K
↓ 102.46%
Investing Cash Flow
-3.4M
↑ 0.0%
Financing Cash Flow
-6.0M
↓ 497328.51%

Technicals Summary

Sell

Neutral

Buy

Core Laboratories Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Core Laboratories Inc
Core Laboratories Inc
24.59%
17.37%
14.96%
-17.55%
-54.26%
Baker Hughes Company
Baker Hughes Company
19.59%
39.11%
30.57%
86.24%
96.32%
Schlumberger Limited
Schlumberger Limited
4.98%
-4.51%
-15.91%
41.85%
19.28%
Technipfmc Plc
Technipfmc Plc
22.54%
20.48%
44.74%
383.99%
58.1%
Nov Inc.
Nov Inc.
8.7%
-8.99%
-12.9%
28.56%
-26.5%
Halliburton Company
Halliburton Company
14.85%
-11.23%
-16.08%
39.05%
49.67%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Core Laboratories Inc
Core Laboratories Inc
39.11
39.11
1.82
0.82
0.11
0.06
0.0
5.34
Baker Hughes Company
Baker Hughes Company
20.13
20.13
0.99
2.3
0.14
0.05
0.02
16.37
Schlumberger Limited
Schlumberger Limited
14.17
14.17
1.98
3.38
0.22
0.08
0.03
15.23
Technipfmc Plc
Technipfmc Plc
20.42
20.42
0.29
1.66
0.2
0.06
0.01
7.66
Nov Inc.
Nov Inc.
6.07
6.07
0.27
1.57
0.18
0.04
0.02
16.61
Halliburton Company
Halliburton Company
11.14
11.14
1.79
3.01
0.26
0.1
0.02
11.73
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Core Laboratories Inc
Core Laboratories Inc
Hold
$991.6M
-54.26%
39.11
5.01%
Baker Hughes Company
Baker Hughes Company
Buy
$44.4B
96.32%
20.13
8.2%
Schlumberger Limited
Schlumberger Limited
Buy
$62.2B
19.28%
14.17
12.44%
Technipfmc Plc
Technipfmc Plc
Buy
$13.1B
58.1%
20.42
7.25%
Nov Inc.
Nov Inc.
Buy
$6.4B
-26.5%
6.07
12.05%
Halliburton Company
Halliburton Company
Buy
$28.0B
49.67%
11.14
11.04%

Insights on Core Laboratories Inc

  • Increasing Revenue

    Revenue is up for the last 5 quarters, 125.34M → 134.39M (in $), with an average increase of 1.7% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, 3.22M → 11.74M (in $), with an average increase of 43.7% per quarter

  • Vs FTI

    In the last 1 year, Technipfmc Plc has given 47.4% return, outperforming this stock by 30.4%

  • Vs FTI

    In the last 3 years, Technipfmc Plc has given 384.0% return, outperforming this stock by 401.6%

Institutional Holdings

  • Ariel Investments, LLC

    21.92%

  • BlackRock Inc

    16.61%

  • Disciplined Growth Investors Inc

    12.04%

  • Vanguard Group Inc

    11.97%

  • Earnest Partners LLC

    7.00%

  • Morgan Stanley - Brokerage Accounts

    4.58%

Company Information

core laboratories is a leading provider of proprietary and patented reservoir description and production enhancement services. core laboratories remains dedicated to providing the technology you need to enhance your production. we continue to develop and acquire technologies that complement our existing products and services, and we disseminate these technologies throughout our global network. with over 70 offices in more than 50 countries located in major oil-producing provinces, core laboratories provides services to the world's major, national, and independent oil companies. we can help you solve your reservoir problems. core laboratories'​ reservoir optimization technologies are used to increase total recovery from existing fields. our services enable our clients to optimize reservoir performance and maximize hydrocarbon recovery from their producing fields. core laboratories has taken extensive measures to ensure the services and data provided by all of our worldwide companies are

Organization
Core Laboratories Inc
Employees
3500
CEO
Mr. Lawrence V. Bruno
Industry
Industrial Services

FAQs